|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52667769
???header.onlineuser??? :
768
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"han cho"???jsp.browse.items-by-author.description???
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2024-11-5 |
Comparative Venous and Arterial Thromboembolism Profiles Associated with Different Cyclin-Dependent Kinase 4/6 Inhibitors: A Real-World Study
|
Chiang;Han, Cho;Lin;Shuwen;Chang;Yu-Cheng;Song;Junmin;Chi;Kuan-Yu;Xanthavanij;Nutchapon;Chang;Yu;Chiang;Cho-Hung;Xu;Haze, Xiaocao |
| 國立成功大學 |
2024-06-1 |
Apixaban versus warfarin for primary thromboprophylaxis in patients with multiple myeloma undergoing immunomodulatory treatment
|
Chang;Yu-Cheng;Chiang;Han, Cho;Tang;Zhiting;See;Ya, Xin;Chiang;Hung, Cho;Chi;Kuan-Yu;Chang;Yu;Gao;Wenli |
| 國立成功大學 |
2024-06-1 |
Direct oral anticoagulant versus low molecular weight heparin for venous thromboembolism in patients receiving immune checkpoint inhibitors
|
Chiang;Han, Cho;Chang;Yu-Cheng;Tang;Zhiting;See;Ya, Xin;Chi;Kuan-Yu;Chang;Yu;Chiang;Hung, Cho;Gong;Jingyi;Curtis;Mary, Lauren;Neilan;Tomas, G. |
| 國立成功大學 |
2024-06-1 |
The impact of glucagon-like peptide 1 agonists on anthracycline or human epidermal growth factor receptor 2 inhibitor-associated cardiotoxicity in patients with breast cancer and diabetes mellitus
|
Chiang;Han, Cho;Chang;Yu-Cheng;Tang;Zhiting;See;Ya, Xin;Chi;Kuan-Yu;Chang;Yu;Chiang;Hung, Cho;Ghamari;Azin;Curtis;Mary, Lauren;Neilan;Tomas, G. |
| 國立成功大學 |
2024-06-1 |
The impact of glucagon-like peptide-1 receptor agonists on proteasome inhibitor-associated cardiotoxicity in patients with multiple myeloma
|
Chang;Yu-Cheng;Chiang;Han, Cho;Tang;Zhiting;See;Ya, Xin;Chiang;Hung, Cho;Chi;Kuan-Yu;Chang;Yu;Gao;Wenli |
Showing items 1-5 of 5 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
